Integer
- Company-Specific Analysis
- All 5 Competitive Forces
- Fully Editable & Customizable
- Clear One-Page Overview
Who owns Integer Holdings Corporation?
Integer Holdings Corporation (NYSE: ITGR) evolved from Greatbatch and now operates globally as a leading medical device outsource manufacturer. Publicly traded, it reports roughly $1.8–$1.9 billion in revenue and mid-teens adjusted EBITDA margins, with ownership held mainly by institutional investors.
Major holders include mutual funds and asset managers; founder family control is minimal and governance reflects institutional shareholder influence. See Integer Porter's Five Forces Analysis for strategic context.
Who Founded Integer?
Founders and Early Ownership of Integer trace to Wilson Greatbatch, who founded Wilson Greatbatch Ltd. in 1970 and retained controlling equity with close associates and early employees while scaling implantable battery and capacitor technologies.
Founding figure
Wilson Greatbatch, an electrical engineer and co-inventor of the implantable pacemaker, established the company in 1970 and served as the primary owner and technical leader.
Early ownership concentration
Equity was concentrated among Greatbatch, a small circle of co-developers and local angel backers within Western New York’s medical device ecosystem.
Limited early VC
Formal venture capital participation was limited through the 1970s and 1980s; growth was financed largely by internal cash flow and local backers.
Employee incentives
As the firm scaled battery and capacitor production for implantables, equity broadened modestly via employee stock and incentive plans to retain technical staff.
Founder protections
Typical founder arrangements—vesting tied to service, IP assignment, and buy-sell provisions—were used to protect proprietary chemistries and provide early liquidity rules.
Dilution over time
During the 1990s and 2000s, founder ownership diluted as the company accessed public markets and executed secondary offerings; portions of the Greatbatch family stake were monetized.
Public records confirm Greatbatch as the controlling founder for the company’s early decades, though specific early split percentages are scarce; for context on later ownership shifts and investor composition see Growth Strategy of Integer.
Key early ownership facts
Concise factual points on founders and early shareholders.
- Founder: Wilson Greatbatch founded Wilson Greatbatch Ltd. in 1970 and retained majority control in early decades.
- Early investors: Small group of co-developers and local angel backers from Western New York; limited VC in 1970s–1980s.
- Equity plans: Employee incentive plans broadened ownership modestly to retain staff and secure IP.
- Later dilution: Public listings and secondary offerings in the 1990s–2000s reduced founder percentage ownership as family stakes were partially sold.
Integer SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Integer’s Ownership Changed Over Time?
Key events shaping the ownership of Integer include the 2005 public listing as Greatbatch, the transformative October 2015 acquisition of Lake Region Medical for approximately $1.73 billion, the 2016 rebrand to Integer Holdings, and a multi-year portfolio optimization and deleveraging campaign through 2016–2024 that shifted the register toward institutional investors.
| Period | Event | Ownership Impact |
|---|---|---|
| 2005 | Public listing as Greatbatch, Inc. | Created a dispersed public float; mutual funds and index funds entered as core holders |
| Oct 2015–2016 | Acquisition of Lake Region Medical (~$1.73 billion); rebrand to Integer Holdings | Institutions financing the deal increased stakes; strategic inflection toward MDO platform |
| 2016–2024 | Portfolio optimization, deleveraging, steady CRM/neuro/vascular growth | Attracted larger passive and active investors; top institutions expanded positions |
| 2024–2025 | Market cap and index inclusion | Market capitalization roughly $4–$6 billion; institutional ownership predominates |
By 2024–2025 the shareholder base is predominantly institutional, with the top-10 holders often aggregating 45–60% of outstanding shares; no single investor holds control per 13F filings and proxy disclosures, and insider ownership remains modest, typically low single digits combined.
Major stakeholder profile
Index and active managers dominate the register; Vanguard, BlackRock, and State Street’s SPDRs are commonly among largest holders, while specialized medtech and small‑mid cap active managers hold meaningful positions.
- Common top holders: Vanguard Group, BlackRock, State Street (via SPDRs)
- Top-10 institutions often hold 45–60% combined
- Insider (executive + director) ownership: typically low single digits
- Market cap range (2024): approximately $4–$6 billion
For ownership data and evolving stakeholder positions, reference 13F filings, annual proxy statements, and investor relations releases; additional context on the company’s revenue model is available at Revenue Streams & Business Model of Integer.
Integer PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Integer’s Board?
Integer's board operates under a single-class, one-share-one-vote capital structure. The board is majority independent and populated by medtech manufacturing, OEM relations, supply chain and finance veterans, typically including the CEO and an independent chair or lead independent director.
| Role | Typical Background | Voting Influence |
|---|---|---|
| Chief Executive Officer (director) | Executive leadership, medtech operations | Standard one-share-one-vote like other holders |
| Independent Chair / Lead Independent Director | Corporate governance, board oversight | Leads independent board agenda, no super-vote |
| Independent Directors | Quality/regulatory, large-cap healthcare, supply chain, finance | Collectively form a majority of directors |
Integer maintains governance practices aligned with institutional investor expectations: annual director elections, independent audit/compensation/nominating committees, and routine say-on-pay votes. There are no dual-class shares, golden shares, or founder super-voting provisions; all common shares carry equal voting rights.
Board composition and shareholder engagement
Board skills mirror an institutional shareholder base focused on governance, capital allocation, and operational improvement.
- One-share-one-vote: single class of common stock governs voting
- Majority independent board with CEO plus independent chair or lead director
- Directors bring medtech manufacturing, OEM, supply chain and finance expertise
- Regular engagement with institutional investors on capital allocation, margins and M&A discipline
Latest public filings (2024–H1 2025) show leading institutional investors as top holders but without designated board seats; typical top 10 shareholders include large asset managers and mutual fund families representing institutional investors focused on governance best practices—see Brief History of Integer for related context.
Integer Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Integer’s Ownership Landscape?
From 2021–2025 Integer’s ownership shifted toward greater passive institutional weight via index inclusion, steady healthcare-focused active funds, and low insider concentration; management prioritized balance-sheet flexibility after the Lake Region integration to support bolt-on M&A and tactical buybacks.
| Trend | 2021–2022 | 2023–2025 |
|---|---|---|
| Institutional ownership | Rising passive allocations as market cap and liquidity improved; top holders included healthcare funds and diversified asset managers | Passive funds increased share; top 10 institutional holders represented roughly 35–45% of float by 2025 |
| Insider ownership | Low executive and director stakes; compensation via equity grants | Remained modest; emphasis on performance-based awards rather than large founder blocks |
| Shareholder returns / capital allocation | Post-acquisition focus on deleveraging and targeted capex | Tactical buybacks authorized and used opportunistically; capex expanded capacity in electrophysiology, neurovascular, structural heart |
| M&A outlook | Lake Region integration completed; balance sheet strengthened | Management signals selective bolt-ons; analysts expect continued consolidation in medtech outsourcing (MDO) |
Revenue mix shifted favorably in 2023–2024 as high-value catheter and delivery systems and neuromodulation components drove top-line growth, improving trading multiples and attracting long-only funds rotating into procedure-recovery beneficiaries.
Ownership composition
Institutional investors hold the bulk of common stock; passive ETFs grow with market cap while healthcare-focused active managers maintain steady positions.
Capital allocation
Free cash flow favored selective buybacks and capex for electrophysiology and structural heart capacity expansion; leverage targets kept conservative post-Lake Region.
M&A and strategic interest
Analysts point to potential strategic or PE interest amid sector consolidation; Integer has not signaled privatization or dual-class moves as of 2025.
Shareholder alignment
Expect continued widely held public float with incremental insider alignment via performance equity rather than concentrated founder ownership.
For a sector and competitor context see Competitors Landscape of Integer; for current top-holder listings and percentages consult 2025 SEC filings (Form 10-K and proxy) and institutional ownership data providers to verify largest institutional owners and detailed shareholder breakdowns.
Integer Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Integer Company?
- What is Competitive Landscape of Integer Company?
- What is Growth Strategy and Future Prospects of Integer Company?
- How Does Integer Company Work?
- What is Sales and Marketing Strategy of Integer Company?
- What are Mission Vision & Core Values of Integer Company?
- What is Customer Demographics and Target Market of Integer Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.